<DOC>
	<DOCNO>NCT00490035</DOCNO>
	<brief_summary>This study evaluate efficacy safety Brivaracetam support submission file indication adjunctive treatment adolescent adults partial onset seizure .</brief_summary>
	<brief_title>Double-blind , Randomized Study Evaluating Efficacy Safety Brivaracetam Adults With Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Subjects 16 70 year , inclusive . Subjects 18 year age include legally permit ethically accepted Subjects wellcharacterized focal epilepsy epileptic syndrome accord International League Against Epilepsy ( ILAE ) classification Subjects history partial onset seizure ( POS ) whether secondarily generalize ( Type I seizures accord ILAE classification ) Subjects least 2 POS whether secondarily generalize per month 3 month precede Visit 1 Subjects least 8 POS whether secondarily generalize 8Week Baseline Period Subjects uncontrolled treat 1 2 permit concomitant antiepileptic drug ( AEDs ) . Vagal nerve stimulation allow count concomitant AED History presence seizure occur cluster ( frequently indistinctly separate reliably count ) Visit 3 History presence status epilepticus year precede Visit 1 Baseline</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Brivaracetam</keyword>
	<keyword>Partial Onset Seizures</keyword>
</DOC>